Responsibilities:
- Develop and execute data-driven territory business plans aligned to brand strategy and launch objectives.
- Analyze territory data to identify growth opportunities and prioritize high-value targets.
- Manage territory budget (including speaker programs and promotional initiatives) and achieve/exceed sales goals.
- Provide compliant, clinically accurate product education within approved labeling.
- Present complex clinical data and value propositions to cardiologists, lipid specialists, endocrinologists, and targeted PCPs; differentiate therapies.
- Execute speaker programs, educational events, and peer-to-peer engagements to drive awareness and adoption.
- Support patient identification and therapy initiation via thoughtful provider engagement.
- Build trust-based relationships with HCPs, office staff, and institutional stakeholders; coordinate within IDNs with Key Account Managers.
- Identify access barriers; collaborate with Market Access and patient services to support pull-through.
- Maintain compliance with company policies/regulations/promotional standards; document activity and manage CRM reporting.
- Partner with Marketing, Medical Affairs, Market Access, Health IT, and Patient Services; provide field insights.
- Represent the company at conferences/meetings (~30% travel); overnight travel as needed.
Qualifications:
- Minimum 5 years pharmaceutical sales experience.
- 3+ years in specialty, rare disease, or cardiovascular areas (strongly preferred).
- Demonstrated success launching/expanding complex therapies requiring access navigation and clinical depth.
- Experience with IDNs/complex healthcare systems (preferred).
Skills/Competencies:
- Data-driven territory planning; strong account management.
- Confident communication of complex clinical data.
- Excellent communication/presentation/relationship-building; strong business acumen.
- Resilience and ability to thrive in a fast-paced launch environment; proven performance.
Compensation & Benefits:
- Base salary: $160,000β$180,000 + incentive (20β30% target).
- RSUs and car allowance; health, dental, vision, and 401(k).